<?xml version="1.0"?>
<!ENTITY % article SYSTEM "http://jats.nlm.nih.gov/archiving/1.2/JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.2" article-type="research-article" xml:lang="en">
      <?properties open_access?>
      <front>
        <journal-meta>
          <journal-id journal-id-type="publisher-id">13321</journal-id>
          <journal-title-group>
            <journal-title>Journal of Cheminformatics</journal-title>
            <abbrev-journal-title abbrev-type="publisher">J Cheminform</abbrev-journal-title>
          </journal-title-group>
          <issn pub-type="epub">1758-2946</issn>
          <publisher>
            <publisher-name>Springer International Publishing</publisher-name>
            <publisher-loc>Cham</publisher-loc>
          </publisher>
        </journal-meta>
        <article-meta>
          <article-id pub-id-type="publisher-id">s13321-019-0370-7</article-id>
          <article-id pub-id-type="manuscript">370</article-id>
          <article-id pub-id-type="doi">10.1186/s13321-019-0370-7</article-id>
          <article-categories>
            <subj-group subj-group-type="heading">
              <subject>Software</subject>
            </subj-group>
          </article-categories>
          <title-group>
            <article-title xml:lang="en">Bioactivity-explorer: a web application for interactive visualization and exploration of bioactivity data</article-title>
          </title-group>
          <contrib-group>
            <contrib contrib-type="author" id="Au1">
              <name>
                <surname>Liang</surname>
                <given-names>Lu</given-names>
              </name>
              <xref ref-type="aff" rid="Aff1">1</xref>
            </contrib>
            <contrib contrib-type="author" id="Au2">
              <name>
                <surname>Ma</surname>
                <given-names>Chunfeng</given-names>
              </name>
              <xref ref-type="aff" rid="Aff1">1</xref>
              <xref ref-type="aff" rid="Aff3">3</xref>
            </contrib>
            <contrib contrib-type="author" id="Au3">
              <name>
                <surname>Du</surname>
                <given-names>Tengfei</given-names>
              </name>
              <xref ref-type="aff" rid="Aff1">1</xref>
            </contrib>
            <contrib contrib-type="author" id="Au4">
              <name>
                <surname>Zhao</surname>
                <given-names>Yufei</given-names>
              </name>
              <xref ref-type="aff" rid="Aff1">1</xref>
              <xref ref-type="aff" rid="Aff3">3</xref>
            </contrib>
            <contrib contrib-type="author" id="Au5">
              <name>
                <surname>Zhao</surname>
                <given-names>Xiaoyong</given-names>
              </name>
              <xref ref-type="aff" rid="Aff1">1</xref>
            </contrib>
            <contrib contrib-type="author" id="Au6">
              <name>
                <surname>Liu</surname>
                <given-names>Mengmeng</given-names>
              </name>
              <xref ref-type="aff" rid="Aff1">1</xref>
              <xref ref-type="aff" rid="Aff3">3</xref>
            </contrib>
            <contrib contrib-type="author" corresp="yes" id="Au7">
              <name>
                <surname>Wang</surname>
                <given-names>Zhonghua</given-names>
              </name>
              <address>
                <email>HIDDEN</email>
              </address>
              <xref ref-type="aff" rid="Aff2">2</xref>
              <xref ref-type="corresp" rid="IDs1332101903707_cor7">g</xref>
            </contrib>
            <contrib contrib-type="author" corresp="yes" id="Au8">
              <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6974-0072</contrib-id>
              <name>
                <surname>Lin</surname>
                <given-names>Jianping</given-names>
              </name>
              <address>
                <email>HIDDEN</email>
              </address>
              <xref ref-type="aff" rid="Aff1">1</xref>
              <xref ref-type="aff" rid="Aff2">2</xref>
              <xref ref-type="aff" rid="Aff3">3</xref>
              <xref ref-type="corresp" rid="IDs1332101903707_cor8">h</xref>
            </contrib>
            <aff id="Aff1">
              <label>1</label>
              <institution-wrap>
                <institution-id institution-id-type="ISNI">0000 0000 9878 7032</institution-id>
                <institution-id institution-id-type="GRID">grid.216938.7</institution-id>
                <institution content-type="org-division">State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research</institution>
                <institution content-type="org-name">Nankai University</institution>
              </institution-wrap>
              <addr-line content-type="street">Haihe Education Park, 38 Tongyan Road</addr-line>
              <addr-line content-type="postcode">300353</addr-line>
              <addr-line content-type="city">Tianjin</addr-line>
              <country country="CN">China</country>
            </aff>
            <aff id="Aff2">
              <label>2</label>
              <institution-wrap>
                <institution-id institution-id-type="ISNI">0000000119573309</institution-id>
                <institution-id institution-id-type="GRID">grid.9227.e</institution-id>
                <institution content-type="org-division">Tianjin Institute of Industrial Biotechnology, Biodesign Center</institution>
                <institution content-type="org-name">Chinese Academy of Sciences</institution>
              </institution-wrap>
              <addr-line content-type="city">Tianjin</addr-line>
              <country country="CN">China</country>
            </aff>
            <aff id="Aff3">
              <label>3</label>
              <institution-wrap>
                <institution-id institution-id-type="GRID">grid.488175.7</institution-id>
                <institution content-type="org-name">Platform of Pharmaceutical Intelligence, Tianjin International Joint Academy of Biomedicine</institution>
              </institution-wrap>
              <addr-line content-type="postcode">300000</addr-line>
              <addr-line content-type="city">Tianjin</addr-line>
              <country country="CN">China</country>
            </aff>
          </contrib-group>
          <author-notes>
            <corresp id="IDs1332101903707_cor7">
              <label>g</label>
              <email>HIDDEN</email>
            </corresp>
            <corresp id="IDs1332101903707_cor8">
              <label>h</label>
              <email>HIDDEN</email>
            </corresp>
          </author-notes>
          <pub-date date-type="pub" publication-format="electronic">
            <day>10</day>
            <month>7</month>
            <year>2019</year>
          </pub-date>
          <pub-date date-type="collection" publication-format="electronic">
            <month>12</month>
            <year>2019</year>
          </pub-date>
          <volume>11</volume>
          <issue seq="47">1</issue>
          <elocation-id>47</elocation-id>
          <history>
            <date date-type="registration">
              <day>2</day>
              <month>7</month>
              <year>2019</year>
            </date>
            <date date-type="received">
              <day>25</day>
              <month>3</month>
              <year>2019</year>
            </date>
            <date date-type="accepted">
              <day>2</day>
              <month>7</month>
              <year>2019</year>
            </date>
            <date date-type="online">
              <day>10</day>
              <month>7</month>
              <year>2019</year>
            </date>
          </history>
          <permissions>
            <copyright-statement content-type="compact">© The Author(s) 2019</copyright-statement>
            <copyright-year>2019</copyright-year>
            <copyright-holder>The Author(s)</copyright-holder>
            <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
              <license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link xlink:href="http://creativecommons.org/licenses/by/4.0/" ext-link-type="uri">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link xlink:href="http://creativecommons.org/publicdomain/zero/1.0/" ext-link-type="uri">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
            </license>
          </permissions>
          <abstract xml:lang="en" id="Abs1">
            <title>Abstract</title>
            <p id="Par1">To better leverage the accumulated bioactivity data in the ChEMBL database, we have developed Bioactivity-explorer, a web application for interactive visualization and exploration of the large-scale bioactivity data in ChEMBL. Mining and integration of the Therapeutic Target Database disease-target mapping into the ChEMBL database has enabled Bioactivity-explorer to include 493,430 scaffolds, 31,400,000 matched molecular pairs, 1330,220 target–target interactions in terms of shared active compounds, 4526,718 target–target interactions in terms of shared active scaffolds, 97,041,700 molecule–molecule interactions and 14,974 disease-target mappings. This web tool is available at <ext-link xlink:href="http://cadd.pharmacy.nankai.edu.cn/b17r" ext-link-type="uri">http://cadd.pharmacy.nankai.edu.cn/b17r</ext-link>. The source codes of the front end and back end, released under MIT license, can be found at GitHub. <fig id="Figa" position="anchor"><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/13321_2019_370_Figa_HTML.png" position="anchor" /></fig></p>
          </abstract>
          <kwd-group xml:lang="en">
            <title>Keywords</title>
            <kwd>Network pharmacology</kwd>
            <kwd>Web server</kwd>
            <kwd>Matched molecular pair</kwd>
            <kwd>Molecule scaffold</kwd>
            <kwd>ChEMBL</kwd>
          </kwd-group>
          <custom-meta-group>
            <custom-meta>
              <meta-name>publisher-imprint-name</meta-name>
              <meta-value>Springer</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>volume-issue-count</meta-name>
              <meta-value>1</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>issue-article-count</meta-name>
              <meta-value>0</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>issue-toc-levels</meta-name>
              <meta-value>0</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>issue-pricelist-year</meta-name>
              <meta-value>2019</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>issue-copyright-holder</meta-name>
              <meta-value>The Author(s)</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>issue-copyright-year</meta-name>
              <meta-value>2019</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>article-contains-esm</meta-name>
              <meta-value>Yes</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>article-numbering-style</meta-name>
              <meta-value>Unnumbered</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>article-registration-date-year</meta-name>
              <meta-value>2019</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>article-registration-date-month</meta-name>
              <meta-value>7</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>article-registration-date-day</meta-name>
              <meta-value>2</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>article-toc-levels</meta-name>
              <meta-value>0</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>toc-levels</meta-name>
              <meta-value>0</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>volume-type</meta-name>
              <meta-value>Regular</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>journal-product</meta-name>
              <meta-value>ArchiveJournal</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>numbering-style</meta-name>
              <meta-value>Unnumbered</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>article-grants-type</meta-name>
              <meta-value>OpenChoice</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>metadata-grant</meta-name>
              <meta-value>OpenAccess</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>abstract-grant</meta-name>
              <meta-value>OpenAccess</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>bodypdf-grant</meta-name>
              <meta-value>OpenAccess</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>bodyhtml-grant</meta-name>
              <meta-value>OpenAccess</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>bibliography-grant</meta-name>
              <meta-value>OpenAccess</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>esm-grant</meta-name>
              <meta-value>OpenAccess</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>online-first</meta-name>
              <meta-value>false</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>pdf-file-reference</meta-name>
              <meta-value>BodyRef/PDF/13321_2019_Article_370.pdf</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>target-type</meta-name>
              <meta-value>OnlinePDF</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>issue-type</meta-name>
              <meta-value>Regular</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>article-type</meta-name>
              <meta-value>OriginalPaper</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>journal-subject-primary</meta-name>
              <meta-value>Chemistry</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>journal-subject-secondary</meta-name>
              <meta-value>Computer Applications in Chemistry</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>journal-subject-secondary</meta-name>
              <meta-value>Documentation and Information in Chemistry</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>journal-subject-secondary</meta-name>
              <meta-value>Theoretical and Computational Chemistry</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>journal-subject-secondary</meta-name>
              <meta-value>Computational Biology/Bioinformatics</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>journal-subject-collection</meta-name>
              <meta-value>Chemistry and Materials Science</meta-value>
            </custom-meta>
            <custom-meta>
              <meta-name>open-access</meta-name>
              <meta-value>true</meta-value>
            </custom-meta>
          </custom-meta-group>
        </article-meta>
        <notes notes-type="ESMHint">
          <title>Electronic supplementary material</title>
          <p>The online version of this article (<ext-link xlink:href="10.1186/s13321-019-0370-7" ext-link-type="doi">https://doi.org/10.1186/s13321-019-0370-7</ext-link>) contains supplementary material, which is available to authorized users.</p>
        </notes>
      </front>
      <body>
        <sec id="Sec1">
          <title>Introduction</title>
          <p id="Par3">In the past decade, open bioactivity data accumulated rapidly in public data repositories such as ChEMBL [<xref ref-type="bibr" rid="CR1">1</xref>], BindingDB [<xref ref-type="bibr" rid="CR2">2</xref>] and PubChem BioAssay [<xref ref-type="bibr" rid="CR3">3</xref>]. For example, the latest release of the ChEMBL database (v24) contains 12,091 targets, 1828,820 distinct compounds and 15,207,914 activities. With the plethora of publicly available bioactivity data, it becomes increasingly important to extract and explore information of interest in drug discovery, especially information derived from large-scale SAR data, for example, matched molecular pairs (MMPs), which describe how structural transformations affect compound properties, including biological activity [<xref ref-type="bibr" rid="CR4">4</xref>]; the scaffold distribution of a specific target [<xref ref-type="bibr" rid="CR5">5</xref>]; and network pharmacology [<xref ref-type="bibr" rid="CR6">6</xref>], which relates targets in terms of shared active ligands, etc. Many studies have been performed to mine the information underlying experimental data repositories. Ye et al. explored all the scaffolds of compounds from the ChEMBL database [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. Paolini et al. [<xref ref-type="bibr" rid="CR8">8</xref>] presented a global mapping of pharmacological space to explore the global relationships between chemical structure and biological targets. By employing the similarity ensemble approach, Keiser et al. related protein pharmacology to ligand chemistry, which was found to reveal unexpected protein target relationships that may be assayed using the ligands themselves. Wirth et al. [<xref ref-type="bibr" rid="CR9">9</xref>] built an MMP database, named SwissBioisostere, by mining the bioactivity data in ChEMBL. Weber et al. also reported an MMP database with 3D information obtained by mining the data from ChEMBL and PDBbind.</p>
          <p id="Par4">However, to our knowledge, there is no tool or web server that provides comprehensive information mining from public bioactivity repositories, as mentioned above. Among the public bioactivity data repositories, the ChEMBL database hosted by the European Bioinformatics Institute is one of the most widely used data sources because of its well-curated bioactivity data and user-friendly downloading format [<xref ref-type="bibr" rid="CR1">1</xref>]. Accordingly, we have developed Bioactivity-explorer, a web application for the interactive visualization and exploration of large-scale bioactivity data in the ChEMBL database.</p>
        </sec>
        <sec id="Sec2">
          <title>Implementation</title>
          <sec id="Sec3">
            <title>Data preparation</title>
            <p id="Par5">The ChEMBL database is the central data repository for Bioactivity-explorer. To maintain consistency with the release pace of the ChEMBL database, we have developed an in-house workflow to help updating data which will be released on GitHub page. Current data were retrieved from the latest ChEMBL (v24) together with the target-diseases data (the ICD-10 diseases classification) from the TTD database [<xref ref-type="bibr" rid="CR10">10</xref>], in which diseases are mapped to ChEMBL targets through Uniprot ID. For example, there are three targets, “Maltase-glucoamylase, intestinal”, “Fibrin” and “Recombinant tetravalent attenuated live dengue”, associated with Dengue fever(A90), and of them the target “Maltase-glucoamylase, intestinal” has Uniprot ID “O43451” which was then mapped to Maltase-glucoamylase (CHEMBL2074) in ChEMBL. To mine more information, essentially following our previous work [<xref ref-type="bibr" rid="CR11">11</xref>], the bioactivity data from ChEMBL were first prepared by the following steps:<list list-type="order"><list-item><p id="Par6">Only activities with valid pChEMBL values (negative logarithms of molar IC50, EC50, Ki, etc.) were considered for future usage, such as scaffold activity, target–target network and MMPs generation, and for molecules with multiple potency measurements reported, the aggregate values (including mean, median, maximum and minimum value) were calculated.</p></list-item><list-item><p id="Par7">The Bemis-Murcko (BM) method [<xref ref-type="bibr" rid="CR12">12</xref>], which is one of the most widely used scaffold-generation methods, was used to generate scaffolds for all structures. The algorithm implemented in RDKit was employed.</p></list-item><list-item><p id="Par8">As in the curation procedure for molecule activity, the aggregated BM scaffold [<xref ref-type="bibr" rid="CR12">12</xref>] activity values were generated from molecules of the scaffold.</p></list-item><list-item><p id="Par9">The definition of “interaction” of target–target and molecule–molecule were derived from the network pharmacology work by Paolini et al. [<xref ref-type="bibr" rid="CR8">8</xref>]. Similar ideas were successfully used in the visualization of the chemical space [<xref ref-type="bibr" rid="CR13">13</xref>] and target prediction [<xref ref-type="bibr" rid="CR14">14</xref>]. Hu et al. [<xref ref-type="bibr" rid="CR15">15</xref>] employ a simple definition that two targets are related to each other if they share at least five active compounds. Inspired by the above studies, the target–target and molecule–molecule interaction relationships, which were defined by the number of shared active molecules/targets, were pre-calculated based on the processed molecule/scaffold activities mentioned above. For example, in the current database there are 57 and 143 ligands with valid pChEMBL against Sucrase-isomaltase (CHEMBL2748) and Maltase-glucoamylase (CHEMBL2074), respectively, and 51 of them are in common. This aggregated data was store in database for target–target network view. It should be mentioned that, in the molecule–molecule interaction generation process, for simplicity, only small molecules with more than 10 activities reported were considered, and only molecular pairs that shared more than 5 targets were stored in the database.</p></list-item></list></p>
            <p id="Par10">For MMP identification of compounds from the same assay, an algorithm implemented in RDKit [<xref ref-type="bibr" rid="CR16">16</xref>] was employed, and of the generated transformations, the one with most heavy atoms (to maximize the transformation) was selected.</p>
          </sec>
          <sec id="Sec4">
            <title>Construction</title>
            <p id="Par11">A user-friendly web interface was developed by combining the Angular framework (<ext-link xlink:href="https://angular.io" ext-link-type="uri">https://angular.io</ext-link>) and the Django framework (<ext-link xlink:href="https://www.djangoproject.com/" ext-link-type="uri">https://www.djangoproject.com/</ext-link>). All data used were stored in a PostgreSQL database. We also implemented a graphql interface (<ext-link xlink:href="https://graphql.org/" ext-link-type="uri">https://graphql.org/</ext-link>), which offers greater query flexibility for the user; a use case is provided in the Results section. The docker files for both the front end and the back end of the tool are provided to facilitate developing, deploying and running the application. Detailed setup instructions can be found at the GitHub repository.</p>
          </sec>
        </sec>
        <sec id="Sec5" sec-type="results">
          <title>Results</title>
          <p id="Par12">The front end of Bioactivity-explorer was built with modern web technology, Angular (<ext-link xlink:href="http://www.angular.io" ext-link-type="uri">www.angular.io</ext-link>) and Angular Material; therefore, to avoid compatibility problems, we strongly recommend the use of the latest versions of web browsers (Google Chrome, Firefox, etc.). Bioactivity-explorer consists of the following main modules: a target/molecule search panel, a target page, a molecule page, a scaffold page, an assay page and a document page.</p>
          <sec id="Sec6">
            <title>Data search and results table</title>
            <p id="Par13">As shown in Fig. <xref rid="Fig1" ref-type="fig">1</xref>, Bioactivity-explorer provides a target/molecule keyword search, molecular structure search, and browser targets by classification. Bioactivity-explorer provides two kinds of target classification: (1) the protein classification taken from the official ChEMBL database and (2) the protein-disease classification derived from the latest Therapeutic Target Database (TTD) [<xref ref-type="bibr" rid="CR10">10</xref>] by mapping targets to the UniProt accession id. The keyword search supports the ChEMBL ID, target and molecule name as input. For the structure search, the JSME applet [<xref ref-type="bibr" rid="CR17">17</xref>] was employed for drawing structures, and then structure and substructure searches of molecules or scaffolds can be performed. The Morgan fingerprint (implemented in RDKit) similarity threshold is adjustable from 0.7 to 1, and set to 1 enables an exact structure search.<fig id="Fig1"><label>Fig. 1</label><caption xml:lang="en"><p>Browsing the target activities of Tuberculosis (A15–A19). Users can perform a keyword search (B), perform a structure search (C), or browse targets by target classification (D) or ICD disease classification (E). Click the menu icon (A) to show or hide the search panel. The table in the right (F) is the result activities. Click ChEMBL ID, accession code and assay number to view corresponding page. Columns followed by “*” are sortable</p></caption><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/13321_2019_370_Fig1_HTML.png" /></fig></p>
          </sec>
          <sec id="Sec7">
            <title>Target information page</title>
            <p id="Par14">One of the central features of Bioactivity-explorer is the target information page. In addition to the basic information on a target, to improve usability, bioactivities, charts based on bioactivity data, target interaction network, MMPs and active scaffolds are also organized into this page. Compared to the charts of a target at the official ChEMBL site, Bioactivity-explorer provides charts with more functionalities. Taking the ligand property histogram as an example (Fig. <xref rid="Fig2" ref-type="fig">2</xref>), the chart in Bioactivity-explorer was further associated with bioactivities. Active and inactive molecules were shown in different colors; therefore, by selecting different activity thresholds and bin sizes, the user can view the compound properties interactively, including the molecular weight, polar surface area (PSA), AlogP, number of heavy atoms, number of aromatic rings, number of rotatable bonds (RTB), number of hydrogen bond donors (HBD) and number of hydrogen bond acceptors (HBA). There is an additional chart about the number of papers published each year on the target, which gives an overview of the research trend of this target.<fig id="Fig2"><label>Fig. 2</label><caption xml:lang="en"><p>Target-associated compound property histogram. Active and inactive molecules are shown in different colors. Below the histogram, the molecule property list, activity threshold and bin size threshold slider options could be used to interact with the chart</p></caption><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/13321_2019_370_Fig2_HTML.png" /></fig></p>
            <p id="Par15">As stated above, the target interaction relationship here was defined by the number of shared active compounds or scaffolds. The “Network” tab on the target page contains a network, as shown in Fig. <xref rid="Fig3" ref-type="fig">3</xref>, illustrating these relationships. An edge that connects two nodes in the network denotes that the two targets have active compounds in common, and the width is proportional to the number of shared compounds. To construct an interactive network view, the node color (color by target type or organism), network type (shared compounds or scaffolds), activity threshold and number of shared compound thresholds are also customizable. The node and edge can be double-clicked to view the corresponding target and compound list, respectively. For some targets with a plethora of bioactivity data, it may take seconds to load the network.<fig id="Fig3"><label>Fig. 3</label><caption xml:lang="en"><p>Target interaction network of Cyclin-dependent kinase 4/cyclin D1. The node and edge denote the target and target–target interaction relationship, and double click on them to view target information and the shared compounds list, respectively. The options below were used to interact with the network</p></caption><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/13321_2019_370_Fig3_HTML.png" /></fig></p>
            <p id="Par16">The “MMP” tab on the target page contains a table of all MMPs derived from the assays of the target (Fig. <xref rid="Fig4" ref-type="fig">4</xref>). Each row of the MMP table is a matched molecular pair and consists of a right handed and left handed molecular structure, structural transformation, activity change, assays and physical property changes including molecular weight, PSA, RTB and Alogp. Finally, the “Scaffold” tab contains all BM scaffolds generated from active molecules of the target, together with the corresponding maximum, mean, median and minimum activity values of the scaffold and the number of underlying compounds. A case study exploring data on the target Cyclin-dependent kinase 5 is provided in the Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>.<fig id="Fig4"><label>Fig. 4</label><caption xml:lang="en"><p>An example of the MMP table. Each row of the table represents an MMP, including the left handed (LH) and right handed (RH) molecule, structural transformation, activity and property changes</p></caption><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/13321_2019_370_Fig4_HTML.png" /></fig></p>
            <p id="Par17">Other pages were organized very similarly to the target page, except for specific data. For example, the “Related Molecules” tab on the molecule page contains molecules that have more than 5 active targets in common.</p>
          </sec>
          <sec id="Sec8">
            <title>The graphql query interface</title>
            <p id="Par18">Graphql is a query language for APIs, and gives the user the power to ask for exactly what they need. The graphql query interface (named graphiq) and the documentation are located at <ext-link xlink:href="http://cadd.pharmacy.nankai.edu.cn/b17r_api/graphql" ext-link-type="uri">http://cadd.pharmacy.nankai.edu.cn/b17r_api/graphql</ext-link>. Figure <xref rid="Fig5" ref-type="fig">5</xref> demonstrates a graphql query (in the left panel) that retrieves the first 10 activities with a pChEMBL value greater than 6 of the target Maltase-glucoamylase (ChEMBL tid 1). The retrieved results are located in the right panel in JSON format.<fig id="Fig5"><label>Fig. 5</label><caption xml:lang="en"><p>The Graphql query interface (graphiql)</p></caption><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/13321_2019_370_Fig5_HTML.png" /></fig></p>
          </sec>
        </sec>
        <sec id="Sec9" sec-type="conclusions">
          <title>Conclusion</title>
          <p id="Par19">We open sourced both the front end and back end of Bioactivity-explorer so that anyone can become directly involved in the development process on GitHub, and researchers who are interested in this tool could build their own local server to use it (which we strongly recommend). In addition to the ChEMBL database, there are still many open and valuable databases that are of great benefit to the drug discovery community; therefore, we expect Bioactivity-explorer to provide an integrated drug development environment for drug discovery and a starting point to integrate more databases.</p>
          <p id="Par20">In summary, based on the ChEMBL database, Bioactivity-explorer consists of 493,430 scaffolds, 31,400,000 MMPs, 1330,220 target–target interactions in terms of shared active compounds, 4526,718 target–target interactions in terms of shared active scaffolds, 97,041,700 molecule–molecule interactions and 14,974 disease-target mappings. For detailed instructions on using Bioactivity-explorer, please refer to the help page.</p>
        </sec>
      </body>
      <back>
        <ack>
          <title>Acknowledgements</title>
          <p>We thank Dr. Pi Liu for valuable suggestions.</p>
        </ack>
        <sec sec-type="author-contribution">
          <title>Authors’ contributions</title>
          <p>LL, ML and TD designed the algorithm for data curation. YZ, LL, XZ, CM and ZW implemented the front end and back end of the tool. ZW, LL and JL wrote the manuscript and discussed the results. All authors read and approved the final manuscript.</p>
        </sec>
        <sec>
          <title>Funding</title>
          <p>This work was supported by the National Key R&amp;D Program of China (No. 2017YFC1104400).</p>
        </sec>
        <sec sec-type="data-availability">
          <title>Availability of data and materials</title>
          <p>The front end and back end of the tool can be found at <ext-link xlink:href="https://github.com/jianping-grp/ng-b17r" ext-link-type="uri">https://github.com/jianping-grp/ng-b17r</ext-link> and <ext-link xlink:href="https://github.com/jianping-grp/b17r" ext-link-type="uri">https://github.com/jianping-grp/b17r</ext-link>, respectively. The tool is also freely available at <ext-link xlink:href="http://cadd.pharmacy.nankai.edu.cn/b17r" ext-link-type="uri">http://cadd.pharmacy.nankai.edu.cn/b17r</ext-link>.</p>
        </sec>
        <sec sec-type="ethics-statement">
          <sec sec-type="COI-statement">
            <title>Competing interests</title>
            <p>The authors declare that they have no competing interests.</p>
          </sec>
        </sec>
        <ref-list id="Bib1">
          <title>References</title>
          <ref-list>
            <ref id="CR1">
              <label>1.</label>
              <mixed-citation publication-type="journal">
                <person-group person-group-type="author">
                  <name>
                    <surname>Gaulton</surname>
                    <given-names>A</given-names>
                  </name>
                  <name>
                    <surname>Hersey</surname>
                    <given-names>A</given-names>
                  </name>
                  <name>
                    <surname>Nowotka</surname>
                    <given-names>M</given-names>
                  </name>
                  <etal />
                </person-group>
                <article-title xml:lang="en">The ChEMBL database in 2017</article-title>
                <source>Nucleic Acids Res</source>
                <year>2017</year>
                <volume>45</volume>
                <fpage>D945</fpage>
                <lpage>D954</lpage>
                <pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1cXhslWhurs%3D</pub-id>
                <pub-id pub-id-type="doi">10.1093/nar/gkw1074</pub-id>
                <pub-id pub-id-type="pmid">27899562</pub-id>
              </mixed-citation>
            </ref>
            <ref id="CR2">
              <label>2.</label>
              <mixed-citation publication-type="journal">
                <person-group person-group-type="author">
                  <name>
                    <surname>Gilson</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name>
                    <surname>Liu</surname>
                    <given-names>T</given-names>
                  </name>
                  <name>
                    <surname>Baitaluk</surname>
                    <given-names>M</given-names>
                  </name>
                  <etal />
                </person-group>
                <article-title xml:lang="en">BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology</article-title>
                <source>Nucleic Acids Res</source>
                <year>2016</year>
                <volume>44</volume>
                <fpage>D1045</fpage>
                <lpage>D1053</lpage>
                <pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXhtV2gu7fM</pub-id>
                <pub-id pub-id-type="doi">10.1093/nar/gkv1072</pub-id>
                <pub-id pub-id-type="pmid">26481362</pub-id>
              </mixed-citation>
            </ref>
            <ref id="CR3">
              <label>3.</label>
              <mixed-citation publication-type="journal">
                <person-group person-group-type="author">
                  <name>
                    <surname>Kim</surname>
                    <given-names>S</given-names>
                  </name>
                  <name>
                    <surname>Thiessen</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name>
                    <surname>Bolton</surname>
                    <given-names>EE</given-names>
                  </name>
                  <etal />
                </person-group>
                <article-title xml:lang="en">PubChem substance and compound databases</article-title>
                <source>Nucleic Acids Res</source>
                <year>2016</year>
                <volume>44</volume>
                <fpage>D1202</fpage>
                <lpage>D1213</lpage>
                <pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXhtV2gu7bE</pub-id>
                <pub-id pub-id-type="doi">10.1093/nar/gkv951</pub-id>
                <pub-id pub-id-type="pmid">26400175</pub-id>
                <pub-id pub-id-type="pmcid">26400175</pub-id>
              </mixed-citation>
            </ref>
            <ref id="CR4">
              <label>4.</label>
              <mixed-citation publication-type="journal">
                <person-group person-group-type="author">
                  <name>
                    <surname>Griffen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name>
                    <surname>Leach</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name>
                    <surname>Robb</surname>
                    <given-names>GR</given-names>
                  </name>
                  <name>
                    <surname>Warner</surname>
                    <given-names>DJ</given-names>
                  </name>
                </person-group>
                <article-title xml:lang="en">Matched molecular pairs as a medicinal chemistry tool</article-title>
                <source>J Med Chem</source>
                <year>2011</year>
                <volume>54</volume>
                <fpage>7739</fpage>
                <lpage>7750</lpage>
                <pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3MXht1Wks7jK</pub-id>
                <pub-id pub-id-type="doi">10.1021/jm200452d</pub-id>
                <pub-id pub-id-type="pmid">21936582</pub-id>
              </mixed-citation>
            </ref>
            <ref id="CR5">
              <label>5.</label>
              <mixed-citation publication-type="journal">
                <person-group person-group-type="author">
                  <name>
                    <surname>Hu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name>
                    <surname>Stumpfe</surname>
                    <given-names>D</given-names>
                  </name>
                  <name>
                    <surname>Bajorath</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title xml:lang="en">Lessons learned from molecular scaffold analysis</article-title>
                <source>J Chem Inf Model</source>
                <year>2011</year>
                <volume>51</volume>
                <fpage>1742</fpage>
                <lpage>1753</lpage>
                <pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3MXptlOrtrc%3D</pub-id>
                <pub-id pub-id-type="doi">10.1021/ci200179y</pub-id>
                <pub-id pub-id-type="pmid">21755989</pub-id>
              </mixed-citation>
            </ref>
            <ref id="CR6">
              <label>6.</label>
              <mixed-citation publication-type="journal">
                <person-group person-group-type="author">
                  <name>
                    <surname>Hopkins</surname>
                    <given-names>AL</given-names>
                  </name>
                </person-group>
                <article-title xml:lang="en">Network pharmacology: the next paradigm in drug discovery</article-title>
                <source>Nat Chem Biol</source>
                <year>2008</year>
                <volume>4</volume>
                <fpage>682</fpage>
                <lpage>690</lpage>
                <pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD1cXht1Kgs7fK</pub-id>
                <pub-id pub-id-type="doi">10.1038/nchembio.118</pub-id>
                <pub-id pub-id-type="pmid">18936753</pub-id>
              </mixed-citation>
            </ref>
            <ref id="CR7">
              <label>7.</label>
              <mixed-citation publication-type="journal">
                <person-group person-group-type="author">
                  <name>
                    <surname>Hu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name>
                    <surname>Stumpfe</surname>
                    <given-names>D</given-names>
                  </name>
                  <name>
                    <surname>Bajorath</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title xml:lang="en">Computational exploration of molecular scaffolds in medicinal chemistry</article-title>
                <source>J Med Chem</source>
                <year>2016</year>
                <volume>59</volume>
                <fpage>4062</fpage>
                <lpage>4076</lpage>
                <pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28XitVygur4%3D</pub-id>
                <pub-id pub-id-type="doi">10.1021/acs.jmedchem.5b01746</pub-id>
              </mixed-citation>
            </ref>
            <ref id="CR8">
              <label>8.</label>
              <mixed-citation publication-type="journal">
                <person-group person-group-type="author">
                  <name>
                    <surname>Paolini</surname>
                    <given-names>GV</given-names>
                  </name>
                  <name>
                    <surname>Shapland</surname>
                    <given-names>RHB</given-names>
                  </name>
                  <name>
                    <surname>Van Hoorn</surname>
                    <given-names>WP</given-names>
                  </name>
                  <etal />
                </person-group>
                <article-title xml:lang="en">Global mapping of pharmacological space</article-title>
                <source>Nat Biotechnol</source>
                <year>2006</year>
                <pub-id pub-id-type="doi">10.1038/nbt1228</pub-id>
                <pub-id pub-id-type="pmid">16841068</pub-id>
              </mixed-citation>
            </ref>
            <ref id="CR9">
              <label>9.</label>
              <mixed-citation publication-type="journal">
                <person-group person-group-type="author">
                  <name>
                    <surname>Wirth</surname>
                    <given-names>M</given-names>
                  </name>
                  <name>
                    <surname>Zoete</surname>
                    <given-names>V</given-names>
                  </name>
                  <name>
                    <surname>Michielin</surname>
                    <given-names>O</given-names>
                  </name>
                  <name>
                    <surname>Sauer</surname>
                    <given-names>WHB</given-names>
                  </name>
                </person-group>
                <article-title xml:lang="en">SwissBioisostere: a database of molecular replacements for ligand design</article-title>
                <source>Nucleic Acids Res</source>
                <year>2013</year>
                <pub-id pub-id-type="doi">10.1093/nar/gks1059</pub-id>
                <pub-id pub-id-type="pmid">23293002</pub-id>
                <pub-id pub-id-type="pmcid">3575799</pub-id>
              </mixed-citation>
            </ref>
            <ref id="CR10">
              <label>10.</label>
              <mixed-citation publication-type="journal">
                <person-group person-group-type="author">
                  <name>
                    <surname>Li</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name>
                    <surname>Yu</surname>
                    <given-names>CY</given-names>
                  </name>
                  <name>
                    <surname>Li</surname>
                    <given-names>XX</given-names>
                  </name>
                  <etal />
                </person-group>
                <article-title xml:lang="en">Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics</article-title>
                <source>Nucleic Acids Res</source>
                <year>2018</year>
                <pub-id pub-id-type="doi">10.1093/nar/gkx1076</pub-id>
                <pub-id pub-id-type="pmid">30312469</pub-id>
                <pub-id pub-id-type="pmcid">6412004</pub-id>
              </mixed-citation>
            </ref>
            <ref id="CR11">
              <label>11.</label>
              <mixed-citation publication-type="journal">
                <person-group person-group-type="author">
                  <name>
                    <surname>Wang</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name>
                    <surname>Li</surname>
                    <given-names>J</given-names>
                  </name>
                  <name>
                    <surname>Dang</surname>
                    <given-names>R</given-names>
                  </name>
                  <etal />
                </person-group>
                <article-title xml:lang="en">PhIN: a protein pharmacology interaction network database</article-title>
                <source>CPT Pharmacometrics Syst Pharmacol</source>
                <year>2015</year>
                <volume>4</volume>
                <fpage>160</fpage>
                <lpage>166</lpage>
                <pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXlvVGms70%3D</pub-id>
                <pub-id pub-id-type="doi">10.1002/psp4.25</pub-id>
              </mixed-citation>
            </ref>
            <ref id="CR12">
              <label>12.</label>
              <mixed-citation publication-type="journal">
                <person-group person-group-type="author">
                  <name>
                    <surname>Bemis</surname>
                    <given-names>GW</given-names>
                  </name>
                  <name>
                    <surname>Murcko</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <article-title xml:lang="en">The properties of known drugs. 1. Molecular frameworks</article-title>
                <source>J Med Chem</source>
                <year>1996</year>
                <volume>39</volume>
                <fpage>2887</fpage>
                <lpage>2893</lpage>
                <pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK28XjvVejtro%3D</pub-id>
                <pub-id pub-id-type="doi">10.1021/jm9602928</pub-id>
                <pub-id pub-id-type="pmid">8709122</pub-id>
              </mixed-citation>
            </ref>
            <ref id="CR13">
              <label>13.</label>
              <mixed-citation publication-type="journal">
                <person-group person-group-type="author">
                  <name>
                    <surname>Fechner</surname>
                    <given-names>N</given-names>
                  </name>
                  <name>
                    <surname>Papadatos</surname>
                    <given-names>G</given-names>
                  </name>
                  <name>
                    <surname>Evans</surname>
                    <given-names>D</given-names>
                  </name>
                  <etal />
                </person-group>
                <article-title xml:lang="en">ChEMBLSpace-a graphical explorer of the chemogenomic space covered by the ChEMBL database</article-title>
                <source>Bioinformatics</source>
                <year>2013</year>
                <pub-id pub-id-type="doi">10.1093/bioinformatics/bts711</pub-id>
                <pub-id pub-id-type="pmid">23257198</pub-id>
              </mixed-citation>
            </ref>
            <ref id="CR14">
              <label>14.</label>
              <mixed-citation publication-type="journal">
                <person-group person-group-type="author">
                  <name>
                    <surname>Keiser</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name>
                    <surname>Roth</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name>
                    <surname>Armbruster</surname>
                    <given-names>BN</given-names>
                  </name>
                  <etal />
                </person-group>
                <article-title xml:lang="en">Relating protein pharmacology by ligand chemistry</article-title>
                <source>Nat Biotechnol</source>
                <year>2007</year>
                <pub-id pub-id-type="doi">10.1038/nbt1284</pub-id>
                <pub-id pub-id-type="pmid">17287757</pub-id>
              </mixed-citation>
            </ref>
            <ref id="CR15">
              <label>15.</label>
              <mixed-citation publication-type="journal">
                <person-group person-group-type="author">
                  <name>
                    <surname>Hu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name>
                    <surname>Bajorath</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title xml:lang="en">Polypharmacology directed compound data mining: identification of promiscuous chemotypes with different activity profiles and comparison to approved drugs</article-title>
                <source>J Chem Inf Model</source>
                <year>2010</year>
                <volume>50</volume>
                <fpage>2112</fpage>
                <lpage>2118</lpage>
                <pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3cXhsVWhtrrM</pub-id>
                <pub-id pub-id-type="doi">10.1021/ci1003637</pub-id>
                <pub-id pub-id-type="pmid">21070069</pub-id>
              </mixed-citation>
            </ref>
            <ref id="CR16">
              <label>16.</label>
              <mixed-citation publication-type="journal">
                <person-group person-group-type="author">
                  <name>
                    <surname>Hussain</surname>
                    <given-names>J</given-names>
                  </name>
                  <name>
                    <surname>Rea</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title xml:lang="en">Computationally efficient algorithm to identify matched molecular pairs (MMPs) in large data sets</article-title>
                <source>J Chem Inf Model</source>
                <year>2010</year>
                <volume>50</volume>
                <fpage>339</fpage>
                <lpage>348</lpage>
                <pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3cXhtlWltr4%3D</pub-id>
                <pub-id pub-id-type="doi">10.1021/ci900450m</pub-id>
                <pub-id pub-id-type="pmid">20121045</pub-id>
              </mixed-citation>
            </ref>
            <ref id="CR17">
              <label>17.</label>
              <mixed-citation publication-type="journal">
                <person-group person-group-type="author">
                  <name>
                    <surname>Bienfait</surname>
                    <given-names>B</given-names>
                  </name>
                  <name>
                    <surname>Ertl</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title xml:lang="en">JSME: a free molecule editor in JavaScript</article-title>
                <source>J Cheminform</source>
                <year>2013</year>
                <pub-id pub-id-type="doi">10.1186/1758-2946-5-24</pub-id>
                <pub-id pub-id-type="pmid">23694746</pub-id>
                <pub-id pub-id-type="pmcid">3662632</pub-id>
              </mixed-citation>
            </ref>
          </ref-list>
        </ref-list>
        <app-group>
          <app id="App1">
            <sec id="Sec10">
              <title>Additional file</title>
              <p>
                <supplementary-material content-type="local-data" id="MOESM1" xlink:title="Additional file">
                  <media mimetype="application" mime-subtype="msword" xlink:href="MediaObjects/13321_2019_370_MOESM1_ESM.docx" position="anchor">
                    <caption xml:lang="en">
                      <p><ext-link xlink:href="https://doi.org/10.1186/s13321-019-0370-7" ext-link-type="uri">Additional file 1.</ext-link> Case study: Exploring bioactivity data of Cyclin-dependent kinase 5.</p>
                    </caption>
                  </media>
                </supplementary-material>
              </p>
            </sec>
          </app>
        </app-group>
        <notes notes-type="Misc">
          <title>Publisher's Note</title>
          <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
        </notes>
      </back>
    </article>
